Prostate cancer is the most common malignancy and second leading cause of cancer death among males in the United States.
Mehmet Sitki Copur, MD, FACP
Burnout is defined as an occupational-related syndrome characterized by physical and emotional exhaustion, cynicism/depersonalization, and low sense of professional accomplishment.
Highlights of breast cancer advances at the ESMO Congress.
The US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.
Immune checkpoint inhibitors have demonstrated impressive activity in patients with CRC and other solid tumors that are dMMR. Researchers explore the data.
Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history.
Clinicians discuss appropriate evaluation and choice of management strategies for cholangiocarcinoma.
Accuracy of current guidelines for genetic testing of breast cancer patients has been recently challenged by a pair of studies suggesting that these guidelines may miss as many patients with pathogenic variants (or genetic mutations) as they may catch.
Atezolizumab is an immune-checkpoint inhibitor, which has been approved by the US Food and Drug Administration (FDA) in various combinations for a number of cancer types in recent years.
A 22-year-old Caucasian woman presents with a four month history of pain, tenderness and swelling in her right breast. What's your diagnosis?